These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21172282)

  • 1. Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II.
    Juillerat P; Vader JP; Felley C; Pittet V; Gonvers JJ; Mottet C; Bemelman WA; Lémann M; Oresland T; Michetti P; Froehlich F;
    J Crohns Colitis; 2009 Dec; 3(4):241-9. PubMed ID: 21172282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II.
    Felley C; Vader JP; Juillerat P; Pittet V; O'Morain C; Panis Y; Vucelic B; Gonvers JJ; Mottet C; Froehlich F; Michetti P;
    J Crohns Colitis; 2009 Dec; 3(4):250-6. PubMed ID: 21172283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach--EPACT.
    Vader JP; Froehlich F; Juillerat P; Burnand B; Felley C; Gonvers JJ; Mottet C; Pittet V; Dubois RW; Wietlisbach V; Michetti P
    Digestion; 2006; 73(4):237-48. PubMed ID: 16940727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.
    Mottet C; Vader JP; Felley C; Froehlich F; Gonvers JJ; Juillerat P; Stockbrügger R; Angelucci E; Seibold F; Michetti P; Pittet V;
    J Crohns Colitis; 2009 Dec; 3(4):257-63. PubMed ID: 21172284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness.
    Juillerat P; Pittet V; Vader JP; Burnand B; Gonvers JJ; de Saussure P; Mottet C; Seibold F; Rogler G; Sagmeister M; Felley C; Michetti P; Froehlich F;
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1352-7. PubMed ID: 20964261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel.
    Pittet V; Froehlich F; Maillard MH; Mottet C; Gonvers JJ; Felley C; Vader JP; Burnand B; Michetti P; Schoepfer A;
    J Crohns Colitis; 2013 Nov; 7(10):820-6. PubMed ID: 23664620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II.
    Michetti P; Stelle M; Juillerat P; Gassull M; Heil FJ; Stange E; Mottet C; Gonvers JJ; Pittet V; Vader JP; Froehlich F; Felley C;
    J Crohns Colitis; 2009 Dec; 3(4):232-40. PubMed ID: 21172281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating appropriateness of treatment for Crohn's disease: feasibility of an explicit approach.
    Guessous I; Juillerat P; Pittet V; Froehlich F; Burnand B; Mottet C; Felley C; Michetti P; Vader JP
    Digestion; 2007; 75(1):46-52. PubMed ID: 17429207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPACT II: project and methods.
    Juillerat P; Froehlich F; Felley C; Pittet V; Mottet C; Gonvers JJ; Michetti P; Vader JP
    Digestion; 2007; 76(2):84-91. PubMed ID: 18239398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort.
    Juillerat P; Pittet V; Mottet C; Felley C; Gonvers JJ; Vader JP; Burnand B; Froehlich F; Wolters FL; Stockbrügger RW; Michetti P;
    Scand J Gastroenterol; 2010 Dec; 45(12):1449-56. PubMed ID: 20653489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriateness of colonoscopy in Europe (EPAGE II). Presentation of methodology, general results, and analysis of complications.
    Juillerat P; Peytremann-Bridevaux I; Vader JP; Arditi C; Schusselé Filliettaz S; Dubois RW; Gonvers JJ; Froehlich F; Burnand B; Pittet V
    Endoscopy; 2009 Mar; 41(3):240-6. PubMed ID: 19280536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.
    Melmed GY; Spiegel BM; Bressler B; Cheifetz AS; Devlin SM; Harrell LE; Irving PM; Jones J; Kaplan GG; Kozuch PL; Velayos FS; Baidoo L; Sparrow MP; Siegel CA
    Clin Gastroenterol Hepatol; 2010 Aug; 8(8):655-9. PubMed ID: 20451665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptance of inflammatory bowel disease treatment recommendations based on appropriateness ratings: do practicing gastroenterologists agree with experts?
    Pittet V; Maillard MH; Lauvergeon S; Timmer M; Michetti P; Froehlich F; Burnand B; Vader JP; Mottet C
    J Crohns Colitis; 2015 Feb; 9(2):132-9. PubMed ID: 25518062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The appropriate management of symptomatic gastro-oesophageal reflux disease (GORD) in primary care: a systematic analysis of expert opinion.
    Stoevelaar HJ; McDonnell J; Stals H; Smets L;
    Acta Gastroenterol Belg; 2003; 66(4):265-70. PubMed ID: 14989047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety considerations when using anti-TNFα therapy to treat Crohn's disease.
    Pagnini C; Arseneau KO; Cominelli F
    Expert Opin Drug Saf; 2015 Jan; 14(1):31-44. PubMed ID: 25400161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of appropriateness criteria for colonoscopy: comparison between a standardized expert panel and an evidence-based medicine approach.
    Nicollier-Fahrni A; Vader JP; Froehlich F; Gonvers JJ; Burnand B
    Int J Qual Health Care; 2003 Feb; 15(1):15-22. PubMed ID: 12630797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriateness of Crohn's disease therapy in gastroenterological rehabilitation.
    Reichel C; Streit J; Ott K; Wunsch S
    Digestion; 2010; 82(4):239-45. PubMed ID: 20588039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.